Status:

COMPLETED

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

Lead Sponsor:

GlaxoSmithKline

Conditions:

Schizophrenia

Eligibility:

All Genders

18+ years

Brief Summary

A direct comparison of Positron Emission Tomography (PET) (11C-Raclopride) and Single Photon Emission Computed Tomography (SPECT) (123I-IBZM) D2 RO measurements would allow GSK to gain understanding o...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Not pregnant or becoming pregnant during the study.
  • No abnormality in clinical examination, clinical laboratory test or ECG.
  • Not taking drugs
  • Patients with schizophrenia, schizophreniform disorder or schizoaffective disorders.
  • Patients with at least 1 month antipsychotic monotherapy with either risperidone, olanzapine or clozapine.
  • Healthy volunteers with no neurological or psychiatric illness.
  • Exclusion criteria:
  • Have received other antipsychotic during the last month or neuroleptics during the last year.
  • If you have taken part in investigations you should not receive a radiation dose of more than 10 mSv over any 3 year period.
  • History of bleeding disorder or are taking medication that affects blood clotting
  • History of substance dependence (except nicotine)
  • Claustrophobia
  • Gross head deformity.
  • Unable to lie still in the PET or SPECT camera for 1 hour and a half.
  • The presence of a cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2007

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT00392743

    Start Date

    December 1 2006

    End Date

    May 1 2007

    Last Update

    November 5 2012

    Active Locations (7)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (7 locations)

    1

    GSK Investigational Site

    Barcelona, Spain, 08003

    2

    GSK Investigational Site

    Barcelona, Spain, 08025

    3

    GSK Investigational Site

    Barcelona, Spain, 08035

    4

    GSK Investigational Site

    Barcelona, Spain, 08036